Point72 Asset Management
PRAX icon

Point72 Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Point72 Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500,000
Closed -$147M – 4330
2025
Q4 		$147M Buy
+500,000
New +$93.1M 0.16% 106
2025
Q1 		– Sell
-150,000
Closed -$11.5M – 2437
2024
Q4 		$11.5M Hold
150,000
– – 0.03% 641
2024
Q3 		$8.63M Buy
+150,000
New +$8.1M 0.02% 690

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Point72 Asset Management's PRAX Position: Q1 2026 in Review

Point72 Asset Management sold out of Praxis Precision Medicines (PRAX) in Q1 2026, closing a stake of 492,346 shares — an estimated $145M sold.

Point72 Asset Management first reported a position in PRAX in Q4 2020 and held it in 21 quarters. The position peaked at $145M in Q4 2025. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Point72 Asset Management reported no remaining Praxis Precision Medicines position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 492,346 Praxis Precision Medicines shares in Q1 2026, an estimated $145M.
  • Point72 Asset Management first reported a position in Praxis Precision Medicines in Q4 2020 and held it in 21 quarters.
  • Point72 Asset Management's Praxis Precision Medicines position peaked at $145M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.